Table 2.
Clinical characteristics during ICU management
| Clinical characteristics | Intervention group | Control group | P -value |
|---|---|---|---|
| Number = 98 | Number = 91 | ||
| ARDS, yes | 4 (4%) | 2 (2%) | 0.684 |
| Antibiotic prophylaxis | 43 (44%) | 43 (47%) | 0.645 |
| NMB agents | 13 (13%) | 5 (5%) | 0.116 |
| Pentothal use, yes | 39 (40%) | 19 (21%) | 0.005 |
| Mannitol use, yes | 49 (50%) | 21 (23%) | <0.001 |
| ICU length of stay, days | 17 ± 13 | 11 ± 8 | <0.001 |
| Mortality, number (%) | 23 (23%) | 31 (34%) | 0.107 |
ARDS: acute respiratory distress syndrome; ICU: intensive care unit; NMB: neuromuscular blocker.